Journey Medical (DERM) Other Accumulated Expenses (2020 - 2026)
Journey Medical (DERM) posted Other Accumulated Expenses of $472000.0 for Q1 2026, down 73.85% on a QoQ basis from $1.8 million in Q4 2025, and down 66.43% year-over-year from $1.4 million in Q1 2025.
Journey Medical (DERM) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Journey Medical's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $472000.0 for Q1 2026.
- Quarterly Other Accumulated Expenses fell 66.43% year-over-year to $472000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $472000.0 (down 66.43% YoY) and the FY2025 annual result came in at $1.8 million, up 302.9% from the prior year.
- Other Accumulated Expenses was $472000.0 for Q1 2026 at Journey Medical, down from $1.8 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $3.8 million in Q1 2022 and bottomed at $195000.0 in Q4 2023.
- A 5-year average of $1.2 million and a median of $755000.0 in 2025 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses slumped 89.23% — and 2025, when it soared 302.9%.
- Journey Medical's Other Accumulated Expenses stood at $413000.0 in 2022, then slumped by 52.78% to $195000.0 in 2023, then surged by 129.74% to $448000.0 in 2024, then surged by 302.9% to $1.8 million in 2025, then slumped by 73.85% to $472000.0 in 2026.
- Business Quant data shows DERM's Other Accumulated Expenses at $472000.0 in Q1 2026, $1.8 million in Q4 2025, and $755000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Journey Medical | 179.67 Mn | 152.45 Mn | 9.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 472,000.00 |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 755,000.00 |
| Jun 30, 2025 | 840,000.00 |
| Mar 31, 2025 | 1.41 Mn |
| Dec 31, 2024 | 448,000.00 |
| Sep 30, 2024 | 370,000.00 |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 195,000.00 |
| Sep 30, 2023 | 636,000.00 |
| Jun 30, 2023 | 751,000.00 |
| Mar 31, 2023 | 678,000.00 |
| Dec 31, 2022 | 413,000.00 |
| Sep 30, 2022 | 2.59 Mn |
| Jun 30, 2022 | 3.03 Mn |
| Mar 31, 2022 | 3.78 Mn |
| Dec 31, 2021 | 3.83 Mn |
| Sep 30, 2021 | 4.50 Mn |
| Dec 31, 2020 | 2.68 Mn |